Have a personal or library account? Click to login
Case Reports on COVID-19 Outcomes During the Pandemic in Patients with Well-Managed HIV Infection in Latvia Cover

Case Reports on COVID-19 Outcomes During the Pandemic in Patients with Well-Managed HIV Infection in Latvia

Open Access
|Mar 2024

References

  1. Ahmed, S., Autrey, J., Katz, I. T., Fox, M. P., Rosen, S., Onoya, D., Bärnighausen, T., Mayer, K. H., Bor, J. (2018). Why do people living with HIV not initiate treatment? A systematic review of qualitative evidence from low- and middle-income countries. Soc. Sci. Med., 213,72–84. DOI: 10.1016/j.socscimed.2018.05.048.
  2. Antinori, A., Cicalini, S., Meschi, S., Bordoni, V., Lorenzini, P., Vergori, A., Lanini, S., De Pascale, L., Matusali, G., Mariotti, D., et al. (2022). Humoral and cellular immune response elicited by mRNA vaccination against aevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in people living with human immunodeficiency virus receiving antiretroviral therapy based on current CD4 T-lymphocyte count. Clin. Infect. Dis., 75 (1), e552–e563. DOI: 10.1093/cid/ciac238.
  3. Ball, S. C. (2014). Increased longevity in HIV: Caring for older HIV-infected adults. Care Management J., 15 (2), 76–82. DOI: 10.1891/1521-0987.15.2.76.
  4. Bhaskaran, K., Rentsch, C. T., MacKenna, B., Schultze, A., Mehrkar, A., Bates, C. J., Eggo, R. M., Morton, C. E., Bacon, S. C. J., Douglas, I. J,, et al. (2021). IV infection and COVID-19 death: A population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV, 8 (1), e24–e32. DOI: 10.1016/S2352-3018(20)30305-2.
  5. CDC (Centers for Disease Control and Prevention). HIV and COVID-19 Basics. https://www.cdc.gov/hiv/basics/covid-19.html (accessed 12.01.2024).
  6. Ceballos, M. E., Ross, P., Lasso, M., Dominguez, I., Puente, M., Valenzuela, P., Enberg, M., Serri, M., Munoz, R., Pinos, Y., et al. (2021). Clinical characteristics and outcomes of people living with HIV hospitalized with COVID-19: A nationwide experience. Int. J. STD AIDS, 32 (5), 435–443. DOI: 10.1177/0956462420973106.
  7. Cooper, T. J., Woodward, B. L., Alom, S., Harky, A. (2020). Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: A systematic review. HIV Med., 21 (9), 567–577. DOI: 10.1111/hiv.12911.
  8. Costiniuk, C. T., Singer, J., Lee, T., Langlois, M. A., Arnold, C., Galipeau, Y., Needham, J., Kulic, I., Jenabian, M. A., Burchell, A. N., et al. (2023). COVID-19 vaccine immunogenicity in people with HIV. AIDS, 37 (1), F1–F10. DOI: 10.1097/QAD.0000000000003429.
  9. Danwang, C., Noubiap, J. J., Robert, A., Yombi, J. C. (2022). Outcomes of patients with HIV and COVID-19 co-infection: A systematic review and meta-analysis. AIDS Res. Ther., 19, 3. DOI: 10.1186/s12981-021-00427-y.
  10. European Centre for Disease Prevention and Control. HIV/AIDS surveil-lance in Europe 2022. https://www.ecdc.europa.eu/en/publications-data/hivaids-surveillance-europe-2023-2022-data (accessed 12.01.2024).
  11. Fung, M., Babik, J. M. (2021). COVID-19 in immunocompromised hosts: What we know so far. Clin. Infect. Dis., 72 (2), 340–350. DOI: 10.1093/cid/ciaa863.
  12. Gong, C., Song, X., Li, X., Lu, L., Li, T. (2022). Immunological changes after COVID-19 vaccination in an HIV-positive patient. Int. J. Infect. Dis., 117, 230–232. DOI: 10.1016/j.ijid.2021.08.039.
  13. HIV.gov. The Global HIV/AIDS Epidemic. https://www.hiv.gov/hiv-basics/overview/data-and-trends/global-statistics (accessed 14.12.2023).
  14. Jakharia, N., Subramanian, A. K., Shapiro, A. E. (2022). COVID-19 in the immunocompromised host, including people with human immunodeficiency virus. Infect. Dis. Clin. North Amer., 36 (2), 397–421. DOI: 10.1016/j.idc.2022.01.006.
  15. Martínez-Sanz, J., Serrano-Villar, S., Vivancos, M. J., Rubio, R., Moreno, S.; HIV-associated comorbidities Study Group (2022). Management of comorbidities in treated HIV infection: A long way to go: HIV, comorbidities and aging. Int. J. Antimicrob. Agents, 59 (1), 106493. DOI: 10.1016/j.ijantimicag.2021.106493.
  16. Nault, L., Marchitto, L., Goyette, G., Tremblay-Sher, D., Fortin, C., Martel-Laferričre, V., Trottier, B., Richard, J., Durand, M., Kaufmann, D., Finzi, A., Tremblay, C. (2022). Covid-19 vaccine immunogenicity in people living with HIV-1. Vaccine, 40 (26), 3633–3637. DOI: 10.1016/j.vaccine.2022.04.090.
  17. Ourworldindata.org. https://ourworldindata.org/covid-vaccinations#what-share-of-the-population-has-received-at-least-one-dose-of-vaccine (accessed 12.01.2024).
  18. Peng, X., Ouyang, J., Isnard, S., Lin, J., Fombuena, B., Zhu, B., Routy, J. P. (2020). Sharing CD4+ T cell loss: When COVID-19 and HIV collide on immune system. Front Immunol., 11, 596631. DOI: 10.3389/fimmu.2020.596631.
  19. Plummer, M. M., Pavia, C. S. (2021). COVID-19 vaccines for HIV-infected patients. Viruses, 13 (10), 1890.DOI:10.3390/v13101890.
  20. Rashedi, R., Samieefar, N., Masoumi, N., Mohseni, S., Rezaei, N. (2022). COVID-19 vaccines mix-and-match: The concept, the efficacy and the doubts. J. Med. Virol., 94 (4), 1294–1299. DOI: 10.1002/jmv.27463.
  21. Sigel, K., Swartz, T., Golden, E., Paranjpe, I., Somani, S., Richter, F., De Freitas, J. K., Miotto, R., Zhao, S., Polak, P., et al. (2020). Coronavirus 2019 and people living with human immunodeficiency virus: Outcomes for hospitalized patients in New York City. Clin. Infect. Dis., 71 (11), 2933–2938. DOI: 10.1093/cid/ciaa880.
  22. SPKC (center for disease prevention and control). https://www.spkc.gov.lv/lv (accessed 20.12.2023).
  23. Tesoriero, J. M., Swain, C. E. Pierce, J. L., Zamboni, L., Wu, M., Holtgrave, D. R., Gonzalez, C. J., Udo, T., Morne, J. E., Hart-Malloy, R., et al. (2021). COVID-19 outcomes among persons living with or without diagnosed HIV infection in New York State. JAMA Netw Open, 4(2), e2037069. DOI: 10.1001/jamanetworkopen.2020.37069. PMID: 33533933; PMCID: PMC7859843.
  24. UNAIDS (2021). http://aidsinfo.unaids.org/ (accessed 12.01.2024).
  25. UNAIDS (2022). Global HIV & AIDS statistics — Fact sheet. https://www.unaids.org/en/resources/fact-sheet.
  26. Vallée, A., Fourn, E., Majerholc, C., Touche, P., Zucman, D. (2021). COVID-19 vaccine hesitancy among French people lving with HIV. Vaccines, 9, 302. DOI:10.3390/vaccines9040302.
  27. Webel, A. R., Schexnayder, J., Cioe, P. A., Zuñiga, J. A. (2021). A review of chronic comorbidities in adults living with HIV: State of the science. J Assoc. Nurses AIDS Care, 32 (3), 322–346. DOI: 10.1097/JNC.0000000000000240. PMID: 33595986; PMCID: PMC8815414.
  28. World Health Organization. WHO COVID-19 Dashboard. World Health Organisation. Published 2023. https://covid19.who.int (accessed 12.01.2024).
DOI: https://doi.org/10.2478/prolas-2024-0015 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 106 - 110
Submitted on: Oct 4, 2022
Accepted on: Jan 24, 2024
Published on: Mar 4, 2024
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2024 Alena Soha, Renata Ņesterenko, Inga Āziņa, Baiba Rozentāle, Jeļena Eglīte, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution 4.0 License.